Facebook Linkedin Twitter
Inside Precision Medicine AI, Dogma, and Drug Development

Triple-negative breast cancer

IPM February 2024 issue Liebman graphic
Informatics

AI, Dogma, and Drug Development

0
Triple negative breast cancer (TNBC) cell undergoing retraction and apoptosis
News & Features

Atezolizumab Add-on Boosts Carboplatin Chemotherapy in Metastatic TNBC

Laura Cowen
0
Woman cancer patient
News & Features

Institute for Systems Biology and NED Biosystems Will Collaborate to Reverse Cancer Onset

0
Breast cancer. TNBC
News & Features

Inhibiting Two Proteins Could Be an Effective Treatment for Triple-Negative Breast Cancer

0
Triple negative breast cancer cell undergoing retraction and apoptosis
News & Features

Drug Targeting Protein May Be Key to Treating Triple-Negative Breast Cancer

0
cancer cells, illustration
News & Features

Neoadjuvant Checkpoint Inhibitor Use Has Untapped Research Benefits Says New Review

0
Dividing breast cancer cell
News & Features

Druggable Target Discovered in Immunotherapy-Resistant Triple-Negative Breast Cancer

0
Conceptual image for viral ethiology of prostate cancer
News & Features

Metabolic Biomarkers Linked to Metastatic Prostate Cancer in Black Men

Laura Cowen
0
Genetic research, liquid biopsy conceptual illustration
Molecular Dx

Medicare Green Lights Coverage of Signatera MRD Test for Breast Cancer

0
Breast cancer. TNBC
News & Features

Oncolytic Virus Treatment May Boost Chemotherapy Response in Triple-Negative Breast Cancer

Laura Cowen
0
123...5Page 2 of 5

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine